Adipose‐derived and bone marrow aspirate concentrate injections for osteoarthritis: A scoping review
PM&R · 2026-05 · 18 (S2)
DOI: 10.1002/pmrj.70147 ↗Kurz gefasst
Scoping Review in der Zeitschrift PM&R, online erschienen am 02.05.2026. Verfasst von Leonardo P Oliveira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Florida, Weston, Florida, USA. Hauptthemen laut MEDLINE: Osteoarthritis, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Osteoarthritis is a leading cause of disability worldwide, and cell‐based treatments including adipose‐derived and bone marrow aspirate have been sought by the lay and medical community as treatment options.
Objective
To perform a scoping review of published literature on cell‐based injections allowed by the U.S. Food and Drug Administration for the treatment of osteoarthritis to synthesize existing evidence and identify research gaps for future evaluation.
Methods
A comprehensive search of five databases was executed from inception through January 2, 2025. Studies that met the inclusion criteria were original research studies written in English on Food and Drug Administration‐allowed cell‐based treatments in adults with osteoarthritis of any joint.
Results
The database search yielded 4257 unique records. After screening, 84 studies met the inclusion criteria, encompassing 9996 patients and a total of 10,508 procedures. The primary research study designs were cohort studies ( n = 62), focused on treatment of knee osteoarthritis ( n = 63), and described bone marrow aspirate ( n = 42) and adipose‐derived ( n = 42) treatments. Postprocedure monitoring ranged from 6 weeks to 5 years, with most studies ≤1 year ( n = 59). Patient‐reported outcomes were reported in 83 of 84 studies; few provided imaging outcomes including magnetic resonance imaging ( n = 9) or radiographs ( n = 2).
Conclusion
This review identified limited randomized controlled trials, limited studies outside the knee, limited description of cell‐based treatments, and treatment protocols, along with inconsistent patient‐reported outcomes limited to 1 year in most studies. We propose establishing reporting guidelines in research on cell‐based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cleveland Clinic Florida, Weston, Florida, USA.
- Cleveland Clinic Akron General, Akron, Ohio, USA.
- University of Alabama at Birmingham, Birmingham, Alabama, USA.
- University of Colorado, Boulder, Colorado, USA.
- University of New Mexico, Albuquerque, New Mexico, USA.
- University of Miami, Miami, Florida, USA.
ORCID-Profile: Leonardo P Oliveira, Aaron Lear, Derek Stokes, Timothy Tiu, Kenneth Mautner
Zitieren
APA
Oliveira, L. P., Lear, A., Elphingstone, J., Stokes, D., Chamberlain, R., Tiu, T., Price, D., Agnew, M., Kliethermes, S., Sund, S., Christensen, L. A., Shapiro, S., & Mautner, K. (2026). Adipose‐derived and bone marrow aspirate concentrate injections for osteoarthritis: A scoping review. PM&R, 18(S2). https://doi.org/10.1002/pmrj.70147
Vancouver
Oliveira LP, Lear A, Elphingstone J, Stokes D, Chamberlain R, Tiu T, et al. Adipose‐derived and bone marrow aspirate concentrate injections for osteoarthritis: A scoping review. PM&R. 2026;18(S2). doi:10.1002/pmrj.70147
BibTeX
@article{Oliveira2026,
author = {Oliveira, Leonardo P and Lear, Aaron and Elphingstone, Joseph and Stokes, Derek and Chamberlain, Rachel and Tiu, Timothy and Price, David and Agnew, Megan and Kliethermes, Stephanie and Sund, Sarah and Christensen, Leslie A and Shapiro, Shane and Mautner, Kenneth},
title = {Adipose‐derived and bone marrow aspirate concentrate injections for osteoarthritis: A scoping review},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S2},
doi = {10.1002/pmrj.70147}
}
EUVIMED